Environmental gynecomastia

Endocrine Practice

Volumn 14, Issue 4, 2008, Pages 409-411

  Braunstein, Glenn D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTRADIOL; ESTRONE; GENISTEIN; PHYTOESTROGEN; ANTIANDROGEN; ESTROGEN;

EDITORIAL; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ESTRADIOL BLOOD LEVEL; FOOD INTAKE; GYNECOMASTIA; HUMAN; MASTALGIA; OCCUPATIONAL EXPOSURE; SOYBEAN MILK; FEMALE; MALE; NOTE;

ANDROGEN ANTAGONISTS; ENVIRONMENTAL EXPOSURE; ESTROGENS; FEMALE; GYNECOMASTIA; HUMANS; MALE; PHYTOESTROGENS;

EID: 58149399925     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.4.409     Document Type: Editorial

References (35)

1. Martinez J, Lewi JE. An unusual case of gynecomastia associated with soy product consumption. Endocr Pract. 2008;14:415-418.
2. Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7:1101-1108.
3. Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 2000;60: 4112-4121.
4. Woodruff TJ, Carlson A, Schwartz JM, Giudice LC. Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary. Fertil Steril. 2008;89(2 Suppl):1-20.
5. Hesselvik L. Signs of sexual precocity in a male infant due to estrogenic ointment. Acta Paediatr. 1952;41:177-185.
6. Green M. Gynecomastia and pseudo-precocious puberty following diethylstilbestrol exposure. AMA J Dis Child. 1958;95:637-639.
7. Landolt R, Mürset G. Premature puberty signs as a result of unintentional estrogen administration [article in German]. Schweiz Med Wochenschr. 1968;98:638-641.
8. Beas F, Vargas L, Spada RP, Merchak N. Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens. J Pediatr. 1969;75:127-130.
9. Gabrilove JL, Luria M. Persistent gynecomastia resulting from scalp inunction of estradiol: a model for persistent gynecomastia. Arch Dermatol. 1978;114:1672-1673.
10. Edidin DV, Levitsky LL. Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child. 1982;136:587-588.
11. Cimorra GA, Gonzalez-Peirona E, Ferrandez A. Percutaneous oestrogen-induced gynaecomastia: a case report. Br J Plastic Surg. 1982;35:209-210.
12. Gottswinter JM, Korth-Schütz, Ziegler R. Gynecomastia caused by estrogen containing hair lotion. J Endocrinol Invest. 1984;7:383-386.
13. Felner EI, White PC. Prepubertal gynecomastia: indirect exposure to estrogen cream. Pediatrics. 2000;105:E55.
14. DiRaimondo CV, Roach AC, Meador CK. Gynecomastia from exposure to vaginal estrogen cream. N Engl J Med. 1980;302:1089-1090.
15. Harrington JM, Stein GF, Rivera RO, de Morales AV. The occupational hazards of formulating oral contraceptives - a survey of plant employees. Arch Environ Health. 1978;33:12-15.
16. Beetz D, Schiller FS. Andrologic changes in workers in the production of oral contraceptives [article in German]. Z Gesamte Hyg. 1969;15:924-927.
17. Prouty M. Gynecomastia with pigmentation in four year old male following stilbestrol exposure. Pediatrics. 1952;9: 55-57.
18. Pacyński A, Budzyńska A, Przylecki S, Robaczyński J. Hyperestrogenism in pharmaceutical factory workers and their children as an occupational disease [article in Polish]. Endokrynol Pol. 1971;22:149-154.
19. Hertz R. Accidental ingestion of estrogens by children. Pediatrics. 1958;21:203-206.
20. Weber WW, Grossman M, Thom JV, Sax J, Chan JJ, Duffy MP. Drug contamination with diethylstilbestrol. Outbreak of precocious puberty due to contaminated isonicotinic acid hydrazide (INH). N Engl J Med. 1963;268: 411-415.
21. Bergogne-Berezin E, Nouhouayi A, Letonturier P, Thibault P, Tourneur R. Letter: Gynecomastia caused by isoniazid. Value of the inactivation phenotype [article in French]. Nouv Presse Med. 1976;5:213-214.
22. National Cancer Institute. PC-SPES (PDQ) Health Professional Version. http://www.cancer.gov/cancertopics/pdq/cam/pc-spes/healthprofessional. Updated December 4, 2007. Accessed for verification April 4, 2008.
23. Fara GM, Del Corvo G, Bernuzzi S, et al. Epidemic of breast enlargement in an Italian school. Lancet. 1979;2: 295-297.
24. Kimball AM, Hamadeh R, Mahmood RA, et al. Gynaecomastia among children in Bahrain. Lancet. 1981;1: 671-672.
25. Vierhapper H, Nowotny P. Gynaecomastia and raised oestradiol concentrations. Lancet. 1999;353:640.
26. Finkelstein JS, McCully WF, MacLaughlin DT, Godine JE, Crowley WF Jr. The mortician's mystery. Gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med. 1988;318:961-965.
27. Bhat N, Rosato EF, Gupta PK. Gynecomastia in a mortician. A case report. Acta Cytol. 1990;34:31-34.
28. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356:479-485.
29. Harmon J, Aliapoulios MA. Gynecomastia in marijuana users. N Engl J Med. 1972;287:936.
30. Cates W Jr, Pope JN. Gynecomastia and cannabis smoking. A nonassociation among US Army soldiers. Am J Surg. 1977;134:613-615.
31. Sauer MA, Rifka SM, Hawks RL, Cutler GB Jr, Loriaux DL. Marijuana: interaction with the estrogen receptor. J Pharmacol Exp Ther. 1983;224:404-407.
32. Gavaler JS, Rosenblum ER, Deal SR, Bowie BT. The phytoestrogen congeners of alcoholic beverages: current status. Proc Soc Exp Biol Med. 1995;208:98-102.
33. Goh SY, Loh KC. Gynaecomastia and the herbal tonic "Dong Quai." Singapore Med J. 2001;42:115-116.
34. Giampietro PG, Bruno G, Furcolo G, et al. Soy protein formulas in children: no hormonal effects in long-term feeding. J Pediatr Endocrinol Metab. 2004;17:191-196.
35. Brody SA, Loriaux DL. Epidemic of gynecomastia among Haitian refugees: exposure to an environmental antiandrogen. Endocr Pract. 2003;9:370-375.